Skip to main content
HYPD logo

HYPD · Hyperion Defi, Inc.

Track HYPD — free
$3.39 -0.02 (-0.59%) At close · Aug 26
Market Cap
$52.99M
Shares
15.54M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.39 Open$3.34 Day$3.20–3.41 52W close$2.34–14.98 Avg vol 30d363K Short int1.5M · 9.9% float · 8.4d Short vol52% Last earningsAug 12, 2026 DataFeb 2025–Aug 2026 Filing10-Q · Aug 13

Raw chart and full-history price indicators begin at the captured split on Feb 3, 2025; bars on opposite sides are not compared.

Up next

Next earnings call
Dec 2, 2026 Est · unconfirmed · in 14 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 13, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Neutral Momentum Neutral Sentiment Very Bullish Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 15.2 · calm Equity put/call 0.64
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg −3%
      below
      Price vs 50-day avg +15%
      above
      RSI (14) 67
      neutral
      MACD trend Positive
      52-week position 8%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Neutral
      1-month return +45%
      trailing
      6-month return +9%
      trailing
      YTD return −5%
      this year
      Relative strength −3%
      vs S&P · 6-mo
      Sentiment
      smart money
      Very Bullish
      Trend (MA cross) No cross
      50d $3 › 200d $3 — 200d above 50d
      Institutional flow Accumulating
      +14% holders QoQ · +10 funds added
      Insider flow Accumulating
      Net +$29.6K over 90 days · 0% sells
      Short interest Falling
      9.91% of float · ▼ -1.3% MoM · 8.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      33 holders — near 1-yr high, broad support
      Squeeze score 79
      high risk · 0–100
      Fundamentals
      Strong
      Revenue growth +1319%
      Y/Y
      Gross margin 63%
      expanding
      EPS growth +84%
      Y/Y
      Free cash flow $-14.9M
      Balance sheet $1.5M
      net debt
      Quant / Vol
      risk profile
      Very High
      Volatility 124%
      annualized · 1-yr
      Max drawdown −84%
      past year
      ATR 7.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Aug 12, 2026
      Adjusted gross profit · 2026 $5M – $7M
      Prior guidance period ended · from the 8-K filed Nov 13, 2025
      Adjusted Revenues · Q4'25 $475,000 – $515,000

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 4 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −3% Neutral
      Price vs 50-day avg
      +15% Bullish
      RSI (14)
      67 Neutral
      MACD trend
      Positive Bullish
      52-week position
      8% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 4 of 6
      Trend (MA cross) No cross
      50d $3 › 200d $3 — 200d above 50d
      Institutional flow Accumulating
      +14% holders QoQ · +10 funds added
      Insider flow Accumulating
      Net +$29.6K over 90 days · 0% sells
      Short interest Falling
      9.91% of float · ▼ -1.3% MoM · 8.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      33 holders — near 1-yr high, broad support
      Price context
      position in its 52-week range
      Range low $2 Now $3 · 8% Range high $15
      vs 200-day avg -3% vs 50-day avg +15%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      % Earned in Cash non-GAAP 50% Q2'26
      Adjusted Net Investing Cash Flow non-GAAP -$6,165,672 Q2 2026
      Adjusted Net Operating Cash Flow non-GAAP -$2,124,382 Q2 2026
      Ending Cash, Cash Equivalents, and Stablecoins non-GAAP $11,758,699 Q2 2026
      Gross HYPE Holdings non-GAAP $132,635,212 As of June 30, 2026
      HYPE tokens earned from staking and validating activities 11.1K Q2'26
      Multiple vs. Staking Yield non-GAAP 2.2 Q2'26
      DeFi Monetization non-GAAP $245K Q1’26
      Ecosystem Rewards non-GAAP $150K Q1’26
      Staking Yield non-GAAP $313K Q1’26
      Validator Commissions non-GAAP $40K Q1’26
      Yield Enhancement non-GAAP $211K Q1’26
      HYPE Tokens delegated to Validator 11.8M December 31, 2025
      Staking Yield in HYPE 8,713 Q4'25
      Trading volumes on Felix-partner markets (cumulative) $2.8B as of March 23, 2026
      Validator Commissions in HYPE 1,362 Q4'25

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Biotechnology — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      HYPD
      Hyperion Defi, Inc.
      this stock
      $52.99M -4.8% +1318.8% 9.9%
      VRTX
      Vertex Pharmaceuticals Inc / Ma
      $138.79B +20.7% +46.2% 31.9 1.6%
      REGN
      Regeneron Pharmaceuticals, Inc.
      $83.89B +5.6% +20.8% 20.2 2.3%
      ARGX
      Argenx SE
      $63.81B +24.5% 1.9%
      CSLLY
      Csl Ltd
      $60.07B 0.0%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      33
      % held
      16.2%
      Net QoQ
      +1.2M sh
      Top holder
      VANGUARD CAPITAL MANAGEME…
      Held Float
      View
      Held by Funds
      Fund positions
      10
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      1.5M
      Days to cover
      8.4d
      Change
      -20.6K sh
      View
      Short Volume
      Short vol %
      52%
      As of
      Aug 26, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      2.6K
      Value
      $6.4K
      As of
      Jul 27, 2026
      View
      Off-Exchange
      Off-exchange %
      53.2%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$29.6K
      Buyers / Sellers
      1 / 0
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $813.5K
      Net income (FY)
      $-45.3M
      EPS diluted
      $-9.40
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 13, 2026
      This year
      12
      View
      Proposed Sales
      Value
      $17.5K
      Shares
      1.4K
      Filed
      Jul 22, 2025
      View
      Exempt Offerings
      Offering
      $50.0M
      Filed
      Jul 22, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 12, 2026
      View

      Performance

      Raw-price comparisons begin at the captured split on Feb 3, 2025; windows that need an earlier baseline remain unavailable.

      5D 20D 120D MTD YTD
      HYPD +11.5% +44.9% +9.4% +28.4% -4.8%
      SPY -0.4% +5.0% +12.4% +2.6% +12.3%
      vs SPY +11.9% +39.9% -3.1% +25.9% -17.1%
      Key facts CIK 1682639 CUSIP 30234E203 13F (30d) 31 filings 31 filers Visit website Investor relations